Finance

Beta
Lists
SGP:NASDAQ
SpyGlass Pharma Inc
$22.26
+2.82%
(+0.61) 1D
$22.26
0.00% (0.00)
After hours
Closed: Jun 30, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGP...
Open
$21.66
High
$22.68
Low
$21.26
Mkt. cap
744.23M
Avg. vol.
122.24K
Volume
81.93K
52-wk high
$32.44
52-wk low
$17.06
No. of employees
68
Open
$21.66
High
$22.68
Low
$21.26
Mkt. cap
744.23M
Avg. vol.
122.24K
Volume
81.93K
52-wk high
$32.44
52-wk low
$17.06
No. of employees
68
News stories
From sources across the web
About SpyGlass Pharma Inc
CEO-
Employees68
Founded2019
HeadquartersAliso Viejo, California, United States
SectorPharmaceutical industry
Websitespyglasspharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to SGP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SGP in the last 3 months.
Highest
Current $22.26
$62.00 (+178.53%)
Average
$47.00 (+111.14%)
Lowest
$37.00 (+66.22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$37.00
+66.2%
05/29/2026
Dennis Ding
Jefferies
Buy
Maintained
$62.00
+178.5%
05/19/2026
Thomas Stephan
Stifel Nicolaus
Buy
Maintained
$42.00
+88.7%
05/15/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$42.00
+88.7%
03/09/2026
Marc Goodman
Leerink Partners
Buy
Initiated
$42.00
+88.7%
03/03/2026
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.69 / -$0.36
-91.67%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.74M
6.05M
7.71M
8.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.01M
1.37M
5.92M
6.87M
Operating expense
7.75M
7.42M
13.63M
15.41M
Total operating expenses
7.75M
7.42M
13.63M
15.41M
Operating income
-7.75M
-7.42M
-13.63M
-15.41M
Other non operating income
-852.98K
-1.53M
11.00
-
EBT including unusual items
-8.40M
-8.82M
-12.56M
-13.82M
EBT excluding unusual items
-8.40M
-8.82M
-12.56M
-13.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.40M
-8.82M
-12.56M
-13.82M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0.69
Interest and investment income
207.42K
126.00K
1.07M
1.59M
Interest expense
-
-
-
-
Net interest expenses
207.42K
126.00K
1.07M
1.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.65M
-7.30M
-13.41M
-15.09M
Gain or loss from assets sale
-
-
1.10K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer